Yubo International Biotech Ltd. (YBGJ)

[Potse]

Q4 advances, subsidiary, social media.......

1) The 2021 Q1 filing should arrive in roughly 2-3 weeks. Ahead of that filing it might be worth noting that YBGJ received more than $750k in advances from prospective customers/distributors during December 2020 (as per the January 14 8-K). I am not sure if this is related to the franchises or other entities but it bodes well for continued revenue/business......

NOTE 9 – ADVANCES FROM PROSPECTIVE CUSTOMERS/DISTRIBUTORS

In December 2020, Yubo Beijing received a total of RMB ¥ 4,948,000 ($757,896) from eight PRC entities in amounts of RMB ¥ 348,000, RMB ¥50,000, RMB ¥50,000, RMB ¥500,000, RMB ¥250,000, RMB ¥500,000, RMB ¥3,000,000 and RMB ¥250,000. The related verbal agreements provide for the eight entities to purchase inventory from Yubo Beijing or enter into such other arrangements with Yubo Beijing as the parties mutually agree. Pending formal approval of any such arrangements, all of the eight PRC entities have the right to request the return of their advances.

2) In January 2021, YBGJ CEO Jun Wang registered a YBGJ wholly-owned subsidiary -- Feibo Refined Biotechnology (Chengdu) Co., Ltd.

https://aiqicha.baidu.com/company_detail_98951490419188

3) Either the company itself or one of the franchise owners appears to have set up an account on the Xiaohongshu social media platform.
Xiaohongshu is a popular social media/commerce/influencer platform where people can talk about or promote products/lifestyles This account is devoted to the Viv Cell franchise and has been active since the late part of April........

https://www.xiaohongshu.com/user/profile/606300b70000000001009b11?language=en-US